Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Sea Ingredients (GSI) is a specialized supplier of marine-derived nutritional ingredients, primarily focused on high-potency Omega-3 fatty acids and krill-based phospholipids. Based in Australia, the company provides essential raw materials for the pharmaceutical, nutraceutical, and functional food industries, supporting therapeutic areas such as cardiovascular health, cognitive function, and metabolic wellness. In 2011, GSI was acquired by Aker BioMarine, a global leader in krill harvesting and biotech, to integrate GSI's advanced processing capabilities and regional market access. The company's portfolio includes sustainably sourced fish oil concentrates and krill oil products that utilize proprietary extraction technologies to ensure high bioavailability and purity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GlobalSea Ingredients.